Global Health

Opioid Crisis: USP’s Comments to the FDA

As government agencies consider solutions to the growing opioid crisis, the Food and Drug Administration (FDA) recently sought public comment about ways to best address this national emergency. USP was pleased to provide our perspective about how public standards might help support the agency’s efforts, and to report on our recent discussions with stakeholders and the standards being considered by USP’s Healthcare Quality Expert Committee.  

Share

Protecting Medicines Quality in Africa: USP presents at 3rd Biennial Scientific Conference on Medical Products Regulation

Protecting Medicines Quality in Africa

Countries throughout Africa are working to harmonize standards to make processes more efficient and help bring needed pharmaceuticals to market, while protecting medicines quality. Learn more

Share

Can changes to prescription labels and other public standards help tame the opioid crisis?

The opioid crisis in the U.S. seems to be part of nearly every news broadcast and news site today. And based on the number of people affected by this crisis, serious conversations about how to help are more important than ever. The CDC estimates that more than 100 Americans die every day from an opioid overdose. And nearly 12 million people – close to 4% of the U.S.

Share

Pages